by 
The global Ambulatory Infusion Center Market is estimated to be valued at US$ 67.84 billion in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Ambulatory Infusion Centers, also known as outpatient infusion centers, provide intravenous therapy and other medical treatments on an outpatient basis. These centers allow patients to receive long-term intravenous antibiotic therapy, chemotherapy, pain management therapies, and other treatments without requiring hospital admission. This helps in reducing healthcare costs for payers and providing convenience to patients.
Ambulatory infusion centers provide services such as hydration therapy, antibiotic and antimicrobial therapy, chemotherapy, pain management, and other therapies. They utilize cutting-edge medical technologies such as automated infusion pumps for precise drug delivery. Major products used in these centers include infusion pumps, intravascular catheters, intravenous equipment, and others. Several medical conditions such as cancer, gastrointestinal disorders, and infectious diseases require long-term IV therapies, driving the demand for outpatient infusion services globally.
The global Ambulatory Infusion Center Market is estimated to be valued at US$ 67.84 billion in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing outpatient care services is expected to drive the growth of the global Ambulatory Infusion Center Market over the forecast period. As mentioned in the heading, the convenience and cost-effectiveness offered by ambulatory infusion centers have led to the growth of outpatient care globally. This is encouraging more patients to opt for long-term outpatient IV therapies instead of lengthy hospital admissions.
Another key driver for the market growth is the growing prevalence of chronic and life-threatening conditions requiring long-term IV medication administration. Diseases such as cancer, immunodeficiency disorders, diabetes, and gastrointestinal disorders account for a large patient pool seeking IV drug therapies. According to the Centers for Disease Control and Prevention (CDC), chronic diseases affect about 60% of American adults. This growing chronic disease burden is anticipated to raise the demand for ambulatory infusion services during the forecast period.
Segment Analysis
The global ambulatory infusion center market is dominated by the chemotherapy sub segment. Chemotherapy accounts for more than 50% of market share owing to the increasing prevalence of cancer globally. There has been tremendous rise in the number of cancer patients diagnosed annually who require chemotherapy treatment in outpatient settings. This has propelled the demand for ambulatory infusion centers that can provide chemotherapy on an outpatient basis in a convenient and cost effective manner.
PEST Analysis
Political: The government bodies in various countries are supporting the development of ambulatory infusion centers through various initiatives and funding to strengthen the healthcare infrastructure and boost access to affordable care. This is positively impacting the market growth.
Economic: Rising healthcare costs have increased the demand for low cost treatment settings like ambulatory infusion centers. They allow treatments and therapies to be delivered in an outpatient setup at nearly 30-50% lower costs than hospitals. This is driving more patients and payers to utilize such centers.
Social: Long waiting times and overcrowding in hospitals is prompting many patients to prefer ambulatory infusion centers for treatments like chemotherapy, immunotherapy and hydration therapy. Their convenience of location and operating timings suited for working professionals is a big social factor spurring their adoption.
Technological: Development of portable infusion devices and pumps along with advanced home care technologies have enabled complex therapies to be effectively administered in outpatient settings. This has empowered the capabilities of ambulatory infusion centers.
Key Takeaways
The global ambulatory infusion center market is expected to witness high growth supported by the rising prevalence of chronic and complex diseases globally.
Regional analysis: The Asia Pacific region is expected to grow the fastest in the ambulatory infusion center market over the forecast period. Countries like China, India and Japan are witnessing expanded medical insurance coverage and growing preference among patients for non-hospital outpatient treatments. This is fueling market growth in the region.
Key players operating in the ambulatory infusion center market are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, PharMerica. Cleveland Clinic, Accredo Health, CHI Health, McLaren, and Envision Healthcare.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
